Ética & Regulação
Health Risks Exposed: Brazil's Urgent Need for Silicone Regulation
Dr. Adrian Vale
LLM, AI Agents & AI Infrastructure Specialist
4 min read
Original sourceListen to Article
AI automated narration
LLM, AI Agents & AI Infrastructure Specialist
The use of industrial silicone in aesthetic procedures in Brazil has led to fatalities, exposing regulatory deficiencies. Experts highlight critical enforcement gaps and call for updated regulations, stricter penalties, and public education to prevent further tragedies.
The misuse of industrial silicone in aesthetic procedures in Brazil has become a public health emergency. Recent high-profile deaths, including those of Carlos Henrique Lacerda and Karoline Vinhas Velasques, underscore the dangers. Industrial silicone, designed for non-medical applications, poses severe risks such as inflammation, infections, and even death when used in humans. Despite these dangers, regulatory loopholes and weak enforcement have allowed these unsafe practices to continue.
Brazil’s regulatory body, the Brazilian Health Regulatory Agency (Anvisa), introduced Resolution No. 36/2015 to manage medical materials. However, enforcement remains insufficient, as illegal use of industrial silicone persists. According to G1, oversight mechanisms fail to prevent these practices, leaving patients unprotected.
The use of non-approved materials violates basic medical ethics, including the principles of beneficence (maximizing benefits) and non-maleficence (avoiding harm). Without accessible public education on the dangers of industrial silicone, patients are often unaware of the risks. This lack of awareness enables unscrupulous practitioners to exploit vulnerable individuals seeking cosmetic enhancements.
Brazil lags behind global standards in regulating aesthetic procedures. A comparison of regulatory practices highlights the disparity:
These international standards demonstrate that comprehensive regulation and enforcement significantly reduce the risks associated with aesthetic procedures.
Experts, including those cited by GZH, outline several steps that Brazil can take to address the issue:
Collaboration between policymakers, healthcare providers, and advocacy groups is essential to foster a safer and more ethical aesthetic industry in Brazil. Protecting public health must remain the top priority.
Industrial silicone can cause severe inflammation, infections, and even death, as it is not approved for human use due to its chemical properties.
Weak enforcement of regulations and insufficient public awareness allow practitioners to continue using industrial silicone illegally in aesthetic procedures.
Experts suggest updating regulations, enhancing enforcement, and launching public awareness campaigns to educate both professionals and consumers.
💡 Dica Pro: Medical device manufacturers could leverage blockchain technology to ensure traceability of materials, reducing the risk of counterfeit products entering the market. This could also align with upcoming regulatory reforms in Brazil.
